StockData

NextCure, Inc. (NXTC) stock

NXTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$6.70+0.02 (+0.30%)

Close on Nov 17, 2026Market cap $30.67MP/E –Yield 0.00%

NextCure profit margin

Profit margin (net margin) is net income as a percentage of revenue.

NextCure's profit margin for the twelve months ending Dec 31, 2020 was -163.6%. For fiscal 2020 it was -163.6%, against -531.5% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2020Dec 31, 2020-163.6%+368.0
FY2019Dec 31, 2019-531.5%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2020Mar 31, 202043.5%+497.1
Q4 FY2019Dec 31, 2019-545.0%–
Q3 FY2019Sep 30, 2019-532.8%–
Q2 FY2019Jun 30, 2019-586.4%–
Q1 FY2019Mar 31, 2019-453.6%–

More NextCure figures

See a number that looks wrong?